Terms: = Uterine cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Treatment
26 results:
1. SUrgical Access and Pattern of Recurrence of Endometrial cancer: The SUPeR Study, a Multicenter Retrospective Observational Study.
Puppo A; Migliaretti G; Landoni F; Uccella S; Camanni M; Ceccaroni M; Delpiano EM; Mantovani G; Roviglione G; Bianchi T; Grassi T; Maggi V; Garzon S; Galli L; Calandra V; Olearo E
J Minim Invasive Gynecol; 2024 Apr; 31(4):321-329. PubMed ID: 38301845
[TBL] [Abstract] [Full Text] [Related]
2. The effects of STA-9090 (Ganetespib) and venetoclax (ABT-199) combination on apoptotic pathways in human cervical cancer cells.
Karademir D; Özgür A
Med Oncol; 2023 Jul; 40(8):234. PubMed ID: 37432531
[TBL] [Abstract] [Full Text] [Related]
3. Bioinformatics Analysis of Novel Targets for Treating Cervical cancer by Immunotherapy Based on Immune Escape.
Han YH; Ma DY; Lee SJ; Mao YY; Sun SY; Jin MH; Sun HN; Kwon T
Cancer Genomics Proteomics; 2023; 20(4):383-397. PubMed ID: 37400149
[TBL] [Abstract] [Full Text] [Related]
4. Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the hsp90a/NDRG1 pathway.
Zheng P; Wu Y; Wang Y; Hu F
Cell Signal; 2023 Sep; 109():110771. PubMed ID: 37329997
[TBL] [Abstract] [Full Text] [Related]
5. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer.
Elasbali AM; Al-Soud WA; Mousa Elayyan AE; Al-Oanzi ZH; Alhassan HH; Mohamed BM; Alanazi HH; Ashraf MS; Moiz S; Patel M; Patel M; Adnan M
J Biomol Struct Dyn; 2023; 41(23):14135-14151. PubMed ID: 36943780
[TBL] [Abstract] [Full Text] [Related]
6. Robot-assisted versus laparoscopic minimally invasive surgery for the treatment of stage I endometrial cancer.
Argenta PA; Mattson J; Rivard CL; Luther E; Schefter A; Vogel RI
Gynecol Oncol; 2022 May; 165(2):347-352. PubMed ID: 35314086
[TBL] [Abstract] [Full Text] [Related]
7. hsp90 promotes radioresistance of cervical cancer cells via reducing FBXO6-mediated CD147 polyubiquitination.
Song Q; Wen J; Li W; Xue J; Zhang Y; Liu H; Han J; Ning T; Lu Z
Cancer Sci; 2022 Apr; 113(4):1463-1474. PubMed ID: 35043518
[TBL] [Abstract] [Full Text] [Related]
8. hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human Cervical cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway.
Hu L; Wang Y; Chen Z; Fu L; Wang S; Zhang X; Zhang P; Lu X; Jie H; Li M; Wang Y; Liu Z
Oxid Med Cell Longev; 2019; 2019():9675450. PubMed ID: 31019655
[TBL] [Abstract] [Full Text] [Related]
9. Pathologic and treatment Outcomes Among a Geriatric Population of Endometrial cancer Patients: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis of lap2.
Bishop EA; Java JJ; Moore KN; Walker JL
Int J Gynecol Cancer; 2017 May; 27(4):730-737. PubMed ID: 28399028
[TBL] [Abstract] [Full Text] [Related]
10. Stress-induced phosphoprotein-1 maintains the stability of JAK2 in cancer cells.
Tsai CL; Chao A; Jung SM; Tsai CN; Lin CY; Chen SH; Sue SC; Wang TH; Wang HS; Lai CH
Oncotarget; 2016 Aug; 7(31):50548-50563. PubMed ID: 27409672
[TBL] [Abstract] [Full Text] [Related]
11. Bioluminescence Imaging to Monitor the Effects of the hsp90 Inhibitor NVP-AUY922 on NF-κB Pathway in Endometrial cancer.
Yeramian A; García V; Bergadà L; Domingo M; Santacana M; Valls J; Martinez-Alonso M; Carceller JA; Cussac AL; Dolcet X; Matias-Guiu X
Mol Imaging Biol; 2016 Aug; 18(4):545-56. PubMed ID: 26604096
[TBL] [Abstract] [Full Text] [Related]
12. [treatment with carbon-ion radiotherapy and its combinations -- basic biological studies and investigations at the National Institute of Radiological Sciences].
Imai T
Gan To Kagaku Ryoho; 2015 Feb; 42(2):154-8. PubMed ID: 25743134
[TBL] [Abstract] [Full Text] [Related]
13. Radiation sensitivity assay with a panel of patient-derived spheroids of small cell carcinoma of the cervix.
Nakajima A; Endo H; Okuyama H; Kiyohara Y; Kimura T; Kamiura S; Hiraoka M; Inoue M
Int J Cancer; 2015 Jun; 136(12):2949-60. PubMed ID: 25408479
[TBL] [Abstract] [Full Text] [Related]
14. Heat shock protein 90 inhibitor mycoepoxydiene modulates kinase signaling in cervical cancer cells and inhibits in-vivo tumor growth.
Lin P; Yi Y; Lu M; Wang M; Yang Y; Lu Y; Song S; Zheng Z; Deng X; Zhang L
Anticancer Drugs; 2015 Jan; 26(1):25-34. PubMed ID: 25014191
[TBL] [Abstract] [Full Text] [Related]
15. Bag-1L is a stress-withstand molecule prevents the downregulation of Mcl-1 and c-Raf under control of heat shock proteins in cisplatin treated HeLa cervix cancer cells.
Ozfiliz P; Arisan ED; Coker-Gurkan A; Obakan P; Eralp TN; Dinler-Doganay G; Palavan-Unsal N
Asian Pac J Cancer Prev; 2014; 15(11):4475-82. PubMed ID: 24969872
[TBL] [Abstract] [Full Text] [Related]
16. Postoperative pain medication requirements in patients undergoing computer-assisted (“Robotic”) and standard laparoscopic procedures for newly diagnosed endometrial cancer.
Leitao MM; Malhotra V; Briscoe G; Suidan R; Dholakiya P; Santos K; Jewell EL; Brown CL; Sonoda Y; Abu-Rustum NR; Barakat RR; Gardner GJ
Ann Surg Oncol; 2013 Oct; 20(11):3561-7. PubMed ID: 23797751
[TBL] [Abstract] [Full Text] [Related]
17. High phospho-Stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition.
Wik E; Birkeland E; Trovik J; Werner HM; Hoivik EA; Mjos S; Krakstad C; Kusonmano K; Mauland K; Stefansson IM; Holst F; Petersen K; Oyan AM; Simon R; Kalland KH; Ricketts W; Akslen LA; Salvesen HB
Clin Cancer Res; 2013 May; 19(9):2331-41. PubMed ID: 23538402
[TBL] [Abstract] [Full Text] [Related]
18. Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells.
Anchoori RK; Khan SR; Sueblinvong T; Felthauser A; Iizuka Y; Gavioli R; Destro F; Isaksson Vogel R; Peng S; Roden RB; Bazzaro M
PLoS One; 2011; 6(8):e23888. PubMed ID: 21909374
[TBL] [Abstract] [Full Text] [Related]
19. Overcoming extreme obesity with robotic surgery.
Stone P; Burnett A; Burton B; Roman J
Int J Med Robot; 2010 Dec; 6(4):382-5. PubMed ID: 20812220
[TBL] [Abstract] [Full Text] [Related]
20. Targeting focal adhesion kinase with dominant-negative FRNK or hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
[TBL] [Abstract] [Full Text] [Related]
[Next]
